Wojciech Wojakowski
Overview
Explore the profile of Wojciech Wojakowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
375
Citations
2858
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gasior M, Wojakowski W, Kalarus Z, Wita K, Golba K, Smolka G, et al.
Kardiol Pol
. 2025 Mar;
PMID: 40066965
No abstract available.
2.
Kaczynski M, Pawlowski T, Dyrbus K, Bujak M, Szkodzinski J, Gasior P, et al.
Kardiol Pol
. 2025 Mar;
PMID: 40066963
No abstract available.
3.
Gasior M, Tajstra M, Deja M, Gil R, Pacholewicz J, Bartus S, et al.
Kardiol Pol
. 2025 Feb;
PMID: 39976500
Background: Cardiogenic shock (CS) remains the leading cause of poor prognosis in patients with acute myocardial infarction (AMI), sustaining a high mortality rate of 40 to 50% within 30 days....
4.
Majewski M, Kulach A, Zorinas A, Januska J, Kilic T, Patel M, et al.
Kardiol Pol
. 2025 Feb;
PMID: 39898839
No abstract available.
5.
Milewski M, Desperak A, Kozlik M, Bujak M, Gierlotka M, Milewski K, et al.
Sci Rep
. 2025 Jan;
15(1):2764.
PMID: 39843545
Myocardial infarction with nonobstructive coronary arteries (MINOCA) constitutes 3-15% of all acute myocardial infarctions. Women are more frequently diagnosed with MINOCA, although the influence of sex on long-term outcomes is...
6.
Ruff C, Patel S, Giugliano R, Morrow D, Hug B, Kuder J, et al.
N Engl J Med
. 2025 Jan;
392(4):361-371.
PMID: 39842011
Background: Abelacimab is a fully human monoclonal antibody that binds to the inactive form of factor XI and blocks its activation. The safety of abelacimab as compared with a direct...
7.
Volleberg R, Rroku A, Mol J, Hermanides R, van Leeuwen M, Berta B, et al.
Circ Cardiovasc Interv
. 2025 Jan;
18(2):e014667.
PMID: 39840429
Background: Despite fractional flow reserve (FFR)-guided deferral of revascularization, recurrent events in patients with diabetes or after myocardial infarction remain common. This study aimed to assess the association between FFR-negative...
8.
Tajstra M, Wilczek K, Witkowski A, Wita K, Stepinska J, Wojakowski W, et al.
Kardiol Pol
. 2025 Jan;
PMID: 39835678
No abstract available.
9.
Wanha W, Wolny R, Kleczynski P, Mattesini A, Iwanczyk S, Dziarmaga M, et al.
Kardiol Pol
. 2025 Jan;
83(2):180-187.
PMID: 39821623
Background: Intravascular lithotripsy (IVL) and excimer laser-coronary atherectomy (ELCA) could be both used in the percutaneous treatment of coronary stent underexpansion. Aims: To investigate the effectiveness and safety of IVL...
10.
Milewski K, Pawlowski T, Kidon-Szoltysek J, Tomaniak M, Gora B, Barus P, et al.
Kardiol Pol
. 2025 Jan;
82(12):1307-1322.
PMID: 39775563
No abstract available.